香烟烟雾改变流量,诱导PP2A膜贩运和内皮细胞透性
Abdoulaye J Dabo1,2, Sonya Raghavan3, Wendy Ezegbunam1
1Division of Pulmonary & Critical Care Medicine, Department of Medicine, State University of New York Downstate Health Sciences University, Brooklyn, NY, USA.
Scientific reports
|November 14, 2024
概括
香烟烟雾通过改变蛋白酸酶2A (PP2A) 活性来破坏肺内皮屏障功能. 这导致细胞透率增加,有助于肺病的进展.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- 气囊毛细管屏障的破坏是慢性阻塞性肺病 (COPD) 的标志,导致,炎症和肺损伤.
- 了解香烟烟雾损害肺内皮屏障功能的分子机制,对于开发向疗法至关重要.
研究的目的:
- 研究香烟烟雾如何调节蛋白酸酶2A (PP2A) 活性和在人肺微血管内皮细胞 (HLMVECs) 中的局部化.
- 阐明PP2A在香烟烟雾引起的内皮膜超透性的作用及其对肺屏障完整性的影响.
主要方法:
- 暴露于香烟烟雾的HLMVECs,并评估了PP2A活性,局部化和奥克卢丁酸化的变化.
- 用药学抑制PP2A和操纵细胞内水平来确定它们对内皮透性的影响.
- 用蛋白质分离和西区块分析分析了PP2A分布和PTP1B活性.
主要成果:
- 暴露在香烟烟雾中降低了整体PP2A活性,并增加了HLMVEC的透性.
- PP2A从细胞质转移到膜,降低了奥克卢丁酸化并增强了屏障泄漏性.
- 香烟烟雾降低了蛋白氨酸酸酶1B (PTP1B) 的活性,这与改变的流量和随后的PP2A失调有关.
- 降低细胞内可以防止香烟烟雾引起的细胞质PP2A活动减少.
结论:
- 香烟烟雾会损害肺内皮屏障功能,因为它会诱导PP2A的依赖的转移到膜上.
- 这种机制涉及PP2A介导的奥克卢丁脱化,导致内皮透性增加,并可能导致COPD病原性.
- 准PP2A或信号通路可能为减轻香烟烟雾引起的肺损伤提供治疗策略.
相关概念视频
Antihypertensive Drugs: Action of Calcium Channel Blockers
459
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
459
Nitric Oxide Signaling Pathway
4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K


